Nephrology Pharmaceutical Care Preceptorship: A programmatic and clinical outcomes assessment

Annals of Pharmacotherapy

Volumn 34, Issue 5, 2000, Pages 593-599

  Matzke, Gary R ^a   St Peter, Wendy L ^a   Comstock, Thomas J ^a   Foote, Edward F ^a  

^a NONE

Author keywords

Dialysis; Nephrology preceptor

Indexed keywords

ARTICLE; CLINICAL PRACTICE; EDUCATION PROGRAM; HEALTH CARE DELIVERY; HEALTH STATUS; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; IRON THERAPY; NEPHROLOGY; OUTCOMES RESEARCH; OUTPATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SELF REPORT;

EID: 0034061601     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19245     Document Type: Article

References (23)

1. US Renal Data System. USRDS 1999 Annual report. Bethesda, MD: The National Institutes of Health, May 1999.
2. Vanholder R. The uremic syndrome. In: Greenberg A, Cheung AK, Coffman TM, Falk RJ, Jennette JC, eds. Primer on kidney disease. 2nd ed. San Diego: Academic Press, 1998:403-7.
3. St Peter WL, Lewis MJ. Chronic renal insufficiency and end-stage renal disease. In: DiPiro JT, Talbert RL, Yee GC, Matzke GM, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach. 4th ed. Stamford, CT: Appleton & Lange, 1999:737-70.
4. Cleary DJ, Matzke GR, Alexander ACM, Joy MS. Medication knowledge and prescription drug taking behavior of patients receiving chronic dialysis. Am J Health Syst Pharm 1995;52:1895-900.
5. Anderson RJ, Melikian DM, Gambertoglio JG, Berns AS, Cadnapaphornchai P, Egan DJ, et al. Prescribing medication in long-term dialysis units. Arch Intern Med 1982;142:1305-8.
6. Tang I, Vrahnos D, Hatoum H, Lau A. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 1993;15:459-64.
7. Kaplan B, Mason NA, Shimp LA, Ascione FJ. Chronic hemodialysis patients. Part 1: characterization and drug-related problems. Ann Pharmacother 1994;28:316-9.
8. Kaplan B, Shimp LA, Mason NA, Ascione FJ. Chronic hemodialysis patients. Part II: reducing drug-related problems through application of the focused drug therapy review program. Ann Pharmacother 1994;28:320-4.
9. Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997;47:117-21.
10. Halstenson CE. Clinical education and postgraduate training opportunities in nephrology pharmacy. J Pharm Pract 1993;6:113-7.
11. Matzke GR. ASHP clinical pharmacy dialysis traineeship. In: Nephrology Pharmacists in the '90s Symposium, 49th Annual Meeting of the American Society of Hospital Pharmacists. Washington, DC, June 2, 1992.
12. Mason NA, St Peter WM, Johnson CA, Bailie GR. Trainees' activities and experiences after a clinical pharmacy dialysis traineeship. Am J Health Syst Pharm 1999;56:1623-36.
13. Conrad W, Szcupak C, Forman H, Gal P. Consultant approach to improving drug-related services to chronic hemodialysis patients. Am J Hosp Pharm 1978;35:558-61.
14. Skoutakis VA, Acchiardo SR, Martinez DR, Lorisch D, Wood GC. Role-effectiveness of the pharmacist in the treatment of hemodialysis patients. Am J Hosp Pharm 1978;35:62-5.
15. Phillips MS, Williams DB, May JR. Using pharmacist clinical intervention data for quality improvement of medication use and physician assessment. Jt Comm J Qual Improv 1994;20:569-76.
16. Raehl CL, Bond CA, Pitterle ME. Pharmacy practice insights: 1995 National Clinical Pharmacy Services Study. Pharmacotherapy 1998;18: 302-26.
17. National Kidney Foundation - dialysis outcomes quality initiative. Clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997;30(suppl 4):S194-240.
18. Pahre S. Nephrology pharmacy practice in the outpatient dialysis setting. Adv Renal Replace Ther 1997;4:179-81.
19. Norwood CE, Pahre S. Clinical pharmacy nephrology practice in the out-patient dialysis center. J Pharm Pract 1993;6:133-9.
20. St Peter WL. Clinical pharmacy nephrology consultation and documentation: a comprehensive approach. J Pharm Pract 1993;6:140-7.
21. St Peter WL, Lambrecht LJ, Macres M. Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients. Am J Kidney Dis 1996;28:523-8.
22. Drivers PS. Cost-effectiveness impact of iron dextran on hemodialysis patients' use of epoetin alfa and blood. Am J Health Syst Pharm 1998; 55(24 suppl 4):S12-6.
23. Matzke GR, Alexander ACM. Kim JJ, Rault RM. Pharmaceutical care in a university medical center-based ambulatory dialysis center. (in press).